On this page we would like to inform you about the latest research progress, meetings, lectures,
publications and results of the PREPARE project.
February 12, 2025:
Dr. Julia Perry and Dr. Felix Rebitschek delivered a lecture as part of the “Biopsychosoziale Mittwochsreihe 2025” on “Risikokommunikation in der zukünftigen hausärztlichen Versorgung: Einstellungen zu und ethische Implikationen einer Alzheimer-Früherkennung” and discussed practical recommendations for action with the participants for advising general practitioners.
January 10, 2025:
In their public Chalk Talk at the Forum Wissen in Göttingen, “Will ich es wissen? Zur Ethik der Risikovorhersage von Altersdemenz,” Prof. Dr. Silke Schicktanz and Dr. Julia Perry explained the ethical tensions between the need for information and the psychological stress of the knowledge while providing insights into their research in medical ethics.
December 09, 2024:
In the scenario workshop “Zwischen Screening und individueller Nachfrage blutbasierter Biomarkertests zur Alzheimer-Früherkennung: Interdisziplinäre Zukunftsvisionen für die Primärversorgung” at Universitätsmedizin Göttingen, eleven experts from various fields developed scenarios for the use of predictive Alzheimer’s tests and reflected on social and ethical implications, political framework conditions, and societal strategies.
November 27, 2024:
At the DGPPN-Kongress 2024 “Psychische Gesundheit in Krisenzeiten” in Berlin, Dr. Julia Perry delivered the lecture “PREPARE – eine ethische Reflexion verschiedener Zukunftsszenarien zum klinischen Einsatz blutbasierter Biomarker.” In two Poster Sessions, she and Gamze Altas-Trippler also presented the posters “Risikokommunikation in der zukünftigen hausärztlichen Versorgung der Alzheimer-Krankheit” (Dr. Julia Perry) and “Untersuchung der hausärztlichen Perspektive auf Blut-Biomarker zur Frühdiagnostik von Alzheimer in der Primärversorgung” (Gamze Altas-Trippler).
November 25, 2024:
In the symposium “Demenz aktiv vorbeugen. Motivation, Prävention und Früherkennung” at the Rhineland-Palatinate State Dementia Office (at the State Office for Social Affairs, Youth and Care) Prof. Dr. Silke Schicktanz spoke on the ethical question regarding early diagnosis: “Testen lassen oder nicht? Frühdiagnostik als ethische Frage.”
November 24, 2024:
Michael Zitzmann presented his poster “Personalised evidence-based risk communication for decision support in the doctor-patient interaction on Alzheimer predictive testing” at the Annual Meeting of the Society for Judgment and Decision-making in New York.
November 24, 2024:
Prof. Dr. Anja Schneider spoke in Toronto at the Neuro2024 (The PSP and CBD International Research Symposium) on
“Plasma Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases.”
October 23-26, 2024:
Participation in the 49th PRACTICA event in Bad Orb, where around 1,000 participants, mainly from GP practices, came together under the theme “da weiß ich noch”. Our research associate Gamze Altas-Trippler presented the PREPARE project and its upcoming online survey, which focuses on early detection of Alzheimer’s disease using biomarkers in GP care and is aimed at interested GPs. Altas-Trippler talked to around 100 GPs, many of whom would like to take part in the study.
September 27, 2024:
Dr. Julia Perry spoke at the annual conference of the Akademie für Ethik in der Medizin (AEM, “Medizin als Beruf – Professionelles Handeln und Denken in den Gesundheitsberufen angesichts gesellschaftlicher Transformationen und technischer Innovationen”) in Tübingen on opportunities and risks of dementia prediction and their political dimension: “Chancen und Risiken der Demenzvorhersage: Wo besteht politischer Handlungsbedarf?”
June 18, 2024:
Prof. Dr. Anja Schneider presented her results on “Plasma extracellular vesicle Tau and TDP-43 as diagnostic biomarkers in FTD and ALS“ at the “European network to cure ALS meeting 2024” in Stockholm.
May 16, 2024:
Felix Rebitschek opened the session “AGREEDementia: Harding Center for Risk Literacy: Study of How People Behave in Situations of Risk and Uncertainty“
with an online lecture for the Advisory Group on Risk Evidence Education for Dementia (AGREED)
May 16, 2024:
Prof. Dr. Anja Schneider gave a talk at the XIII Biennial Conference Barcelona Pittsburgh on “A blood-based biomarker for detection of TDP-43 and Tau pathology in FTD spectrum disorders.“
April 20, 2024:
Dr. Julia Perry spoke at the Auguste Symposium (Eisai; medical-scientific continuing education event on Alzheimer’s disease/dementia) in Frankfurt am Main on the ethical aspects of diagnosing and treating dementia “Ethische Aspekte in Diagnostik und Therapie dementieller Erkrankungen.“
March 19, 2024:
Felix Rebitschek presented an online keynote speech in the Marburger Bund webinar “Die Zukunft des Gesundheitswesens: Wie kann KI zur ärztlichen Versorgung beitragen?” on „Bedingungen einer nutzenbringenden Implementierung von algorithmischer Entscheidungsunterstützung für Gesundheitsfachkräfte.”
March 7, 2024:
Prof. Dr. Anja Schneider presented “Plasma extracellular vesicle tau isoform ratios and tdp-43 inform about molecular pathology in frontotemporal dementia and amyotrophic lateral sclerosis“ at the AD/PD™ Conference 2024 in Lisbon and discussed their diagnostic relevance.